{"data":[{"accessionNo":"0001493215-26-000161","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc.","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":7796895,"percentOfClass":7.9,"filedAt":"2026-08-14"},{"accessionNo":"0001493215-26-000161","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc.","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":7796895,"percentOfClass":7.9,"filedAt":"2026-08-14"},{"accessionNo":"0001167557-26-000169","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc.","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"AQR Capital Management Holdings, LLC","reportingCik":null,"personType":"HC","sharesOwned":6560809,"percentOfClass":6.66,"filedAt":"2026-08-13"},{"accessionNo":"0001167557-26-000169","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc.","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"AQR Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":6560809,"percentOfClass":6.66,"filedAt":"2026-08-13"},{"accessionNo":"0000093751-26-000549","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC","ticker":"RARE","cusip":"90400D108","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":6158766,"percentOfClass":6.3,"filedAt":"2026-08-07"},{"accessionNo":"0002100121-26-001001","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":6853427,"percentOfClass":6.95,"filedAt":"2026-07-31"},{"accessionNo":"0002100119-26-001487","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":5058419,"percentOfClass":5.13,"filedAt":"2026-07-31"},{"accessionNo":"0002012383-26-003116","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":8141384,"percentOfClass":8.3,"filedAt":"2026-07-30"},{"accessionNo":"0000093751-26-000302","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMACEUTICAL INC","ticker":"RARE","cusip":"90400D108","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":5021441,"percentOfClass":5.1,"filedAt":"2026-05-12"},{"accessionNo":"0002100121-26-000786","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":5410208,"percentOfClass":5.5,"filedAt":"2026-04-29"},{"accessionNo":"0000102909-26-002574","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001515673","issuerName":"Ultragenyx Pharmaceutical Inc","ticker":"RARE","cusip":"90400D108","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27"},{"accessionNo":"0000315066-26-000545","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMA INC","ticker":"RARE","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3347890.21,"percentOfClass":3.5,"filedAt":"2026-02-05"},{"accessionNo":"0000315066-26-000545","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMA INC","ticker":"RARE","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3347890.21,"percentOfClass":3.5,"filedAt":"2026-02-05"},{"accessionNo":"0000315066-25-002839","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMA INC","ticker":"RARE","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":7964937.47,"percentOfClass":8.3,"filedAt":"2025-11-05"},{"accessionNo":"0000315066-25-002839","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001515673","issuerName":"ULTRAGENYX PHARMA INC","ticker":"RARE","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":7964937.47,"percentOfClass":8.3,"filedAt":"2025-11-05"}],"updatedAt":"2026-10-14T00:59:18.285Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}